Metropolis Healthcare Ltd
Thu 13/03/2025,15:54:14 | NSE : Metropolis
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 1615.00
Previous Close
₹ 1623.25
Volume
86124
Mkt Cap ( Rs. Cr)
₹8338.82
High
₹ 1634.20
Low
₹ 1608.10
52 Week High
₹ 2318.30
52 Week Low
₹ 1527.60
Book Value Per Share
₹ 230.87
Dividend Yield
0.00
Face Value
₹ 2.00
What’s Your Call?
Collective community sentiment on Metropolis Healthcare Ltd
Your Vote -
Buy
57.14%
Hold
28.57%
Sell
14.29%
57.14%
21 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
0%
Sell Order Quantity
100%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
1626.10
3
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
3
Option Chain
Analyzes market sentiment, predicts Metropolis Healthcare Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Metropolis Healthcar - Analysts/Institutional Investor Meet/Con. Call Updates
-
Metropolis Healthcar - Sale or disposal-XBRL
-
Metropolis Healthcar - Acquisition-XBRL
-
Metropolis Healthcar - Acquisition-XBRL
-
Metropolis Healthcar - Press Release
-
Metropolis Healthcar - General Updates
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Acquisition
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Metropolis Healthcar - Analysts/Institutional Investor Meet/Con. Call Updates
-
Metropolis Healthcar - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Metropolis Healthcar - Resignation
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Change in Management
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Metropolis Healthcar - Analysts/Institutional Investor Meet/Con. Call Updates
-
Metropolis Healthcar - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Metropolis Healthcar - Shareholders meeting
-
Metropolis Healthcar - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
-
Metropolis Healthcar - Update-Acquisition/Scheme/Sale/Disposal-XBRL
-
Metropolis Healthcar - General Updates
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Updates on Acquisition
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Metropolis Healthcar - Analysts/Institutional Investor Meet/Con. Call Updates
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Metropolis Healthcar - Analysts/Institutional Investor Meet/Con. Call Updates
-
Metropolis Healthcar - Copy of Newspaper Publication
-
Metropolis Healthcar - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Metropolis Healthcar - Investor Presentation
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Metropolis Healthcar - Press Release
-
Metropolis Healthcar - Integrated Filing- Financial
-
Metropolis Healthcar - Integrated Filing (Financial)
-
Metropolis Healthcar Q3 net profit up 2.62% at Rs 27.40 cr
-
Metropolis Healthcar - Outcome of Board Meeting
-
Metropolis Healthcar - Board Meeting Outcome for The Meeting Held Today (February 04, 2025)
-
Metropolis Healthcar - Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months
-
Metropolis Healthcar - Financial Result Updates
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Metropolis Healthcar - Analysts/Institutional Investor Meet/Con. Call Updates
-
Metropolis Healthcar - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Metropolis Healthcar - Resignation
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Change in Management
-
Metropolis Healthcar - Board Meeting Intimation
-
Metropolis Healthcar - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Metropolis Healthcar - Analysts/Institutional Investor Meet/Con. Call Updates
-
Metropolis Healthcar - Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Finan
-
Metropolis Healthcar has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024
-
Metropolis Healthcar - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Metropolis Healthcar - Updates
-
Metropolis Healthcar - Change In The Name Of The Registrar And Transfer Agent Of The Company
-
Metropolis Healthcar - Updates
-
Metropolis Healthcar - Business Update For Q3FY25
-
Metropolis Healthcar - Trading Window-XBRL
-
Metropolis Healthcar - Trading Window
-
Metropolis Healthcar - Incorporation-XBRL
-
Metropolis Healthcar - General Updates
-
Metropolis Healthcar - Analysts/Institutional Investor Meet/Con. Call Updates
-
Metropolis Healthcar - Transcript Of Investor Conference Call
-
Metropolis Healthcare
-
Metropolis Healhcare
-
Metropolis Healthcare
-
Metropolis Healthcare
-
Metropolis Healthcare
-
Viewpoint – Metropolis Healthcare
-
Metropolis Healthcare
-
Metropolis Healthcare
-
Viewpoint: Metropolis Healthcare
-
Metropolis Healthcare Q2FY22
-
CRISIL raises Metropolis’ ratings
-
Metropolis Healthcare
-
Viewpoint: Metropolis Healthcare
-
Metropolis launch new laboratory in Kochi
-
Metroplis Healthcare
-
Metropolis Healthcare
-
Metropolis Healthcare
Key fundamentals
Evaluate the intrinsic value of Metropolis Healthcare Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | March-20 |
---|---|---|---|---|---|
Assets | 1031.1872 | 1018.3087 | 1082.6745 | 708.9253 | 512.3846 |
Liabilities | 1031.1872 | 1018.3087 | 1082.6745 | 708.9253 | 512.3846 |
Equity | 10.2454 | 10.2421 | 10.2343 | 10.2233 | 10.1261 |
Gross Profit | 258.4812 | 269.3104 | 305.0844 | 239.3733 | 172.6047 |
Net Profit | 115.8898 | 138.9473 | 192.2414 | 197.5551 | 112.0543 |
Cash From Operating Activities | 269.0076 | 237.7385 | 237.1506 | 202.4967 | 156.1298 |
NPM(%) | 10.5 | 13.03 | 17.2 | 24.2 | 16.84 |
Revenue | 1103.4254 | 1066.0407 | 1117.1306 | 816.1083 | 665.3071 |
Expenses | 844.9442 | 796.7303 | 812.0462 | 576.735 | 492.7024 |
ROE(%) | 9.78 | 11.73 | 16.23 | 16.68 | 9.46 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|---|---|---|---|
17 Nov 2023 | 4 | 200 | 0 | 1571.55 |
23 Feb 2023 | 8 | 400 | 0 | 1249.75 |
21 Feb 2022 | 8 | 400 | 0 | 2560.4 |
17 Feb 2021 | 8 | 400 | 0 | 2228.5 |
13 Feb 2020 | 8 | 400 | 0 | 1586.25 |
Peers
Other companies within the same industry or sector that are comparable to Metropolis Healthcare Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 808.20 | -1.14 | 11.41 | 925.85 | 1321.50 | 1.42 |
Lotus Eye Hospital and Institute Ltd | 57.06 | -0.77 | 237.75 | 3373.68 | 14.01 | 0.88 |
Vaishali Pharma Ltd | 12.12 | -5.90 | 606.00 | 1738.92 | 2.31 | 0.00 |
Astec Lifesciences Ltd | 653.90 | -5.55 | 0.00 | 3181.09 | -239.30 | 0.00 |
Company Info
Dr. Sushil Kanubhai Shah, one of The Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners. The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards. In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr. Sushil Kanubhai Shah and Dr. Duru Sushil Shah. Prior to March 18, 1995, Dr. Sushil Kanubhai Shah was also carrying on a business of radioimmunoassay and pathology laboratory on a sole proprietorship basis. On March 20, 1995, the said sole proprietorship business was converted into a partnership with Dr. Sushil Kanubhai Shah, Dr. Duru Sushil Shah and Aparna S. Shah (Rajadhyaksha) as partners, in the name and style of Metropolis Lab. In January 1998, Ameera Sushil Shah was inducted as an additional partner in Metropolis Lab. With effect from February 1, 2002, the business of Metropolis Lab was transferred to Dr. V. K. Desai's Hospital as a going concern. In May 2002, Dr. G. S. K. Velu and Subbulakshmi K. Velu were admitted as partners in Dr. V. K. Desai Hospitals. The name of Dr. V. K. Desai's Hospital was changed to Metropolis Health Services in November 2002. Further, in April 2003, Ameera Sushil Shah, Jaswanti Kanubhai Shah, Sadacharan Gomanthybabu and Gomathybabu Gomathy were admitted as partners in Metropolis Health Services.In July 2003, Metropolis Health Services was converted into a private limited company as Metropolis Health Services (India) Private Limited ("MHSIPL") under the Companies Act, 1956. The name of MHSIPL was changed to Metropolis Health Services (India) Limited ("MHSIL") pursuant to a `Fresh Certificate of Incorporation Consequent upon Change of Name on Conversion to Public Limited Company' granted by RoC on March 1, 2006. In January 2009, MHSIL amalgamated with Pathnet India Private Limited, which was a wholly owned subsidiary of MHSIL. For details, see "- Scheme of amalgamation between Pathnet India Private Limited and Metropolis Health Services (India) Limited, Metro Home Health Services Private Limited, Lister Metropolis Laboratory and Research Centre Private Limited, Tripoli Path Lab Private Limited and Diwanchand Metropolis Diagnostics Services Private Limited".Pathnet India Private Limited was incorporated at New Delhi as a private limited company under the Companies Act, 1956 pursuant to the `Certificate of Incorporation' granted by the Registrar of Companies, N. C. T. of Delhi and Haryana on November 10, 2000. The name of The Company was changed to Pathnet India Limited pursuant to a `Fresh Certificate of Incorporation Consequent upon Change of Name on Conversion to Public Limited Company' granted by RoC on July 1, 2009. The name of The Company was changed to Metropolis Healthcare Limited pursuant to a `Fresh Certificate of Incorporation Consequent upon Change of Name' granted by RoC on September 23, 2009. Major events and milestones of The Company :2002-First major acquisition by the Company of Sudharma2004-The Company was accredited by National Accreditation Board for Testing and Calibration Laboratories (Department of Science & Technology, India)2005-The Company received accreditation from The College of American Pathologists2006-Investment by The Western India Trustee and Executor Company in the Company-Acquisition of M/s. Lister Laboratory and Research Centre Private Limited in Chennai2007-Acquisition of Desai Clinical Laboratory in Surat2008-Acquisition of R.V Diagnostics & Healthcare Center Private Limited in Bangalore2009-Scheme of Amalgamation 20092010-Investment by Foxcreek Investment Limited in the Company2011-Acquisition of LabOne in Raipur2012-Acquisition of Micron Laboratories in Mumbai-Acquisition of subsidiary in Kenya-Acquisition of Dr. Patel Pathology Laboratory Private Limited in Nashik-Incorporation of subsidiary in Mauritius2013-Acquisition of M/s. Ekopath Center-Pathology and Cytology Division in Guwahati-Establishment of GRL in Mumbai2014-Acquisition of subsidiary in Ghana2015-Investment by CA Lotus Investments in the Company-Incorporation of subsidiary in Uganda-Incorporation of branch office in Zambia2017-Acquisition of Sanjeevani Pathology Laboratory in Rajkot2018-Public-Private partnership agreement executed with National AIDS Control Organisation, Government of India-Scheme of Amalgamation 2018-Incorporation of subsidiary in Tanzania Awards, achievements and certifications :2010-The Company was awarded the "Diagnostic Services Company of the Year" by Frost & Sullivan2012-The Company was felicitated for providing "Outstanding Quality Diagnostic Services" by HIV Congress 20122014-The Company was awarded the "Most Promising Brand" by the World Consulting and Research Corporation-The Company was awarded as a "Quality Brand" by Quality Brands India2015-The Company was awarded the "Best Diagnostic Company of the Year" at the National Awards for Excellence in Healthcare 2015-The Company was awarded the "Diagnostic Services Company of the Year" by the VCCircle Network-The Company was awarded for "Excellence in Productive Employment Creation" by Business Today2018-The Company was awarded for "Best in Health and Fitness" in the Digital Campaign Awards by LH Insights-The Company was awarded for "Excellence in Customer Service & Delivery" by Biotrains-The Company was awarded special jury mention for "Service Excellence (Diagnostic Centre)" by FICCI at the Healthcare Excellence Awards2018-2019-The Company was awarded "Iconic Pathology Lab Mumbai" by Midday Health & Wellness Icons 2020 -Metropolis Healthcare wins India CSR award for "Too Shy To Ask" App. -India Diagnostic service provider company of the year 2020.
Dr. Sushil Kanubhai Shah, one of The Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners. The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards. In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr. Sushil Kanubhai Shah and Dr. Duru Sushil Shah. Prior to March 18, 1995, Dr. Sushil Kanubhai Shah was also carrying on a business of radioimmunoassay and pathology laboratory on a sole proprietorship basis. On March 20, 1995, the said sole proprietorship business was converted into a partnership with Dr. Sushil Kanubhai Shah, Dr. Duru Sushil Shah and Aparna S. Shah (Rajadhyaksha) as partners, in the name and style of Metropolis Lab. In January 1998, Ameera Sushil Shah was inducted as an additional partner in Metropolis Lab. With effect from February 1, 2002, the business of Metropolis Lab was transferred to Dr. V. K. Desai's Hospital as a going concern. In May 2002, Dr. G. S. K. Velu and Subbulakshmi K. Velu were admitted as partners in Dr. V. K. Desai Hospitals. The name of Dr. V. K. Desai's Hospital was changed to Metropolis Health Services in November 2002. Further, in April 2003, Ameera Sushil Shah, Jaswanti Kanubhai Shah, Sadacharan Gomanthybabu and Gomathybabu Gomathy were admitted as partners in Metropolis Health Services.In July 2003, Metropolis Health Services was converted into a private limited company as Metropolis Health Services (India) Private Limited ("MHSIPL") under the Companies Act, 1956. The name of MHSIPL was changed to Metropolis Health Services (India) Limited ("MHSIL") pursuant to a `Fresh Certificate of Incorporation Consequent upon Change of Name on Conversion to Public Limited Company' granted by RoC on March 1, 2006. In January 2009, MHSIL amalgamated with Pathnet India Private Limited, which was a wholly owned subsidiary of MHSIL. For details, see "- Scheme of amalgamation between Pathnet India Private Limited and Metropolis Health Services (India) Limited, Metro Home Health Services Private Limited, Lister Metropolis Laboratory and Research Centre Private Limited, Tripoli Path Lab Private Limited and Diwanchand Metropolis Diagnostics Services Private Limited".Pathnet India Private Limited was incorporated at New Delhi as a private limited company under the Companies Act, 1956 pursuant to the `Certificate of Incorporation' granted by the Registrar of Companies, N. C. T. of Delhi and Haryana on November 10, 2000. The name of The Company was changed to Pathnet India Limited pursuant to a `Fresh Certificate of Incorporation Consequent upon Change of Name on Conversion to Public Limited Company' granted by RoC on July 1, 2009. The name of The Company was changed to Metropolis Healthcare Limited pursuant to a `Fresh Certificate of Incorporation Consequent upon Change of Name' granted by RoC on September 23, 2009. Major events and milestones of The Company :2002-First major acquisition by the Company of Sudharma2004-The Company was accredited by National Accreditation Board for Testing and Calibration Laboratories (Department of Science & Technology, India)2005-The Company received accreditation from The College of American Pathologists2006-Investment by The Western India Trustee and Executor Company in the Company-Acquisition of M/s. Lister Laboratory and Research Centre Private Limited in Chennai2007-Acquisition of Desai Clinical Laboratory in Surat2008-Acquisition of R.V Diagnostics & Healthcare Center Private Limited in Bangalore2009-Scheme of Amalgamation 20092010-Investment by Foxcreek Investment Limited in the Company2011-Acquisition of LabOne in Raipur2012-Acquisition of Micron Laboratories in Mumbai-Acquisition of subsidiary in Kenya-Acquisition of Dr. Patel Pathology Laboratory Private Limited in Nashik-Incorporation of subsidiary in Mauritius2013-Acquisition of M/s. Ekopath Center-Pathology and Cytology Division in Guwahati-Establishment of GRL in Mumbai2014-Acquisition of subsidiary in Ghana2015-Investment by CA Lotus Investments in the Company-Incorporation of subsidiary in Uganda-Incorporation of branch office in Zambia2017-Acquisition of Sanjeevani Pathology Laboratory in Rajkot2018-Public-Private partnership agreement executed with National AIDS Control Organisation, Government of India-Scheme of Amalgamation 2018-Incorporation of subsidiary in Tanzania Awards, achievements and certifications :2010-The Company was awarded the "Diagnostic Services Company of the Year" by Frost & Sullivan2012-The Company was felicitated for providing "Outstanding Quality Diagnostic Services" by HIV Congress 20122014-The Company was awarded the "Most Promising Brand" by the World Consulting and Research Corporation-The Company was awarded as a "Quality Brand" by Quality Brands India2015-The Company was awarded the "Best Diagnostic Company of the Year" at the National Awards for Excellence in Healthcare 2015-The Company was awarded the "Diagnostic Services Company of the Year" by the VCCircle Network-The Company was awarded for "Excellence in Productive Employment Creation" by Business Today2018-The Company was awarded for "Best in Health and Fitness" in the Digital Campaign Awards by LH Insights-The Company was awarded for "Excellence in Customer Service & Delivery" by Biotrains-The Company was awarded special jury mention for "Service Excellence (Diagnostic Centre)" by FICCI at the Healthcare Excellence Awards2018-2019-The Company was awarded "Iconic Pathology Lab Mumbai" by Midday Health & Wellness Icons 2020 -Metropolis Healthcare wins India CSR award for "Too Shy To Ask" App. -India Diagnostic service provider company of the year 2020.
Read More
Parent Organisation
Metropolis Healthcare Ltd.
Founded
01/03/2006
Managing Director
Mrs.Ameera Sushil Shah
NSE Symbol
METROPOLISEQ
FAQ
The current price of Metropolis Healthcare Ltd is ₹ 1626.10.
The 52-week high for Metropolis Healthcare Ltd is ₹ 1634.20 and the 52-week low is ₹ 1608.10.
The market capitalization of Metropolis Healthcare Ltd is currently ₹ 8338.82. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Metropolis Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Metropolis Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Metropolis Healthcare Ltd shares.
The CEO of Metropolis Healthcare Ltd is Mrs.Ameera Sushil Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.